Akebia Therapeutics Lower Following Announcement Of Public Offering, Corporate And Clinical Developments
January 05, 2016 at 09:03 AM EST
Shares of Akebia Therapeutics Inc (NASDAQ: AKBA), a biopharmaceutical company that focuses on products for the treatment of kidney ...